Valuation: Tiansheng Pharmaceutical Group Co., Ltd.

Market Cap 1.44B 211M 185M 171M 160M 300M 19.93B 306M 2.05B 794M 9.85B 793M 776M 34.16B P/E 2024
-16.5x
P/E 2025 -27.9x
Enterprise Value 1.52B 223M 195M 180M 169M 316M 21.03B 323M 2.17B 838M 10.39B 837M 819M 36.03B EV / Sales 2024
2.7x
EV / Sales 2025 3.16x
Free-Float
51.3%
Yield 2024 *
-
Yield 2025 -
08/05 Tiansheng Pharmaceutical Secures Proposed Selection for Three Medicines in China's National Procurement MT
29/04 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
29/04 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
13/02 Three Tiansheng Pharma Drugs Set to Win Bids for China's Drug Procurement Program MT
07/11 Tiansheng pharmaceutical and its controlling shareholder penalised, fined RE
30/10/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
14/10/25 Tiansheng Pharmaceutical Group Subsidiaries Tentatively Win Bulk Drug Tenders in Guangdong MT
15/09/25 Tiansheng Pharmaceutical Gets China Supplementary Drug Approval for Sodium Bicarbonate Injection MT
27/08/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
29/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
29/04/25 Tiansheng Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
10/02/25 Tiansheng Pharmaceutical Passes Consistency Evaluation for Antibiotic MT
26/12/24 Chongqing Pharmaceutical Group Changsheng Pharmaceutical Co., Ltd announced that it expects to receive CNY 60 million in funding from C.Q. Pharmaceutical Holding Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd. CI
1 day-2.59%
1 week-8.32%
Current month-16.30%
1 month-18.12%
3 months-12.91%
6 months-7.00%
Current year-7.00%
1 week 4.47
Extreme 4.47
4.96
1 month 4.47
Extreme 4.47
5.56
Current year 4.47
Extreme 4.47
5.65
1 year 4.47
Extreme 4.47
5.81
3 years 3.17
Extreme 3.17
5.97
5 years 3.17
Extreme 3.17
5.99
10 years 3.17
Extreme 3.17
35.18
Manager TitleAgeSince
Chief Executive Officer 33 06/12/2018
Director of Finance/CFO 52 23/12/2013
Corporate Officer/Principal 54 11/12/2020
Director TitleAgeSince
Chairman 33 06/12/2018
Director/Board Member 54 11/12/2020
Director/Board Member 66 11/12/2020
Date Insider Type Main position Quantity % Market Cap.
25/07/23Sell

Chief Financial Officer

43,100 0.0205%
Change 5-day change 1-year change 3-year change Capi.($)
-2.59%-8.32%-3.42%-10.67% 211M
+7.13%+9.97%+55.80%+163.38% 1,077B
+3.99%+11.50%+67.09%+56.27% 613B
+4.20%+17.03%+38.97%+91.19% 448B
+0.31%+4.85%+28.17%+22.04% 332B
-0.45%+7.16%+40.73%+26.75% 293B
-0.89%+4.11%+30.21%+40.49% 286B
-1.88%+4.00%-29.04%-41.52% 215B
+1.56%+6.14%+29.30%+61.91% 193B
+3.26%+3.33%+15.55%+67.87% 159B
Average +0.67%+6.99%+27.34%+47.77% 361.63B
Weighted average by Cap. +1.77%+9.65%+41.62%+80.72%

Financials

2024 2025
Net sales 570M 83.75M 73.43M 67.69M 63.37M 119M 7.9B 121M 814M 315M 3.9B 314M 308M 13.54B 514M 75.57M 66.26M 61.08M 57.18M 107M 7.13B 109M 734M 284M 3.52B 284M 278M 12.22B
Net income -87.4M -12.85M -11.27M -10.38M -9.72M -18.23M -1.21B -18.61M -125M -48.3M -599M -48.25M -47.19M -2.08B -55.42M -8.15M -7.14M -6.58M -6.16M -11.56M -769M -11.8M -79.15M -30.62M -380M -30.59M -29.93M -1.32B
Net Debt 97.19M 14.29M 12.53M 11.55M 10.81M 20.27M 1.35B 20.69M 139M 53.7M 666M 53.65M 52.48M 2.31B 78.93M 11.6M 10.17M 9.38M 8.78M 16.46M 1.09B 16.8M 113M 43.61M 541M 43.57M 42.62M 1.88B
Logo Tiansheng Pharmaceutical Group Co., Ltd.
Tiansheng Pharmaceutical Group Co Ltd is a China-based company primarily engaged in drug R&D, production, sales, and the cultivation and processing of traditional Chinese medicinal materials. The Company's products include tablets, capsules, granules, teas, pills, and injections. Product varieties cover pediatrics, gynecology, cardiovascular system, digestive system, orthopedics, respiratory medicine, and anti-infective treatment areas. The Company's products are mainly sold to the domestic market.
Employees
1,273
Date Price Change Volume
26/06/26 CNY 4.520 -2.59% 2,367,850
25/06/26 CNY 4.640 -2.32% 3,190,850
24/06/26 CNY 4.750 -2.86% 3,156,500
23/06/26 CNY 4.890 +1.24% 4,040,000
  1. Stock Market
  2. Stocks
  3. 002872 Stock